A Multicenter Long-Term Study of Imatinib Treatment for Japanese Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors

Ogata Kyoichi; Mochiki Erito; Ojima Hitoshi; Haga Norihiro; Fukuchi Minoru; Aihara Ryuusuke; Ando Hiroyuki; Uchida Nobuyuki; Toyomasu Yoshitaka; Suzuki Masaki; Kimura Akiharu; Kogure Norimichi; Yokobori Takehiko; Ohno Tetsuro; Kuwano Hiroyuki

首页> 外文期刊>Journal of Surgical Oncology >A Multicenter Long-Term Study of Imatinib Treatment for Japanese Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors

【24h】

A Multicenter Long-Term Study of Imatinib Treatment for Japanese Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors

机译：伊马替尼治疗日本不可切除或复发性胃肠道间质瘤患者的多中心长期研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and ObjectivesThis multicenter study, which was conducted in northern Kanto, Japan, aimed to assess the efficacy of imatinib mesylate against advanced or recurrent gastrointestinal stromal tumors (GIST).

机译：背景与目的这项多中心研究在日本关东北部进行，旨在评估甲磺酸伊马替尼对晚期或复发性胃肠道间质瘤（GIST）的疗效。

著录项

来源
《Journal of Surgical Oncology 》 |2014年第8期| 共5页
作者
Ogata Kyoichi; Mochiki Erito; Ojima Hitoshi; Haga Norihiro; Fukuchi Minoru; Aihara Ryuusuke; Ando Hiroyuki; Uchida Nobuyuki; Toyomasu Yoshitaka; Suzuki Masaki; Kimura Akiharu; Kogure Norimichi; Yokobori Takehiko; Ohno Tetsuro; Kuwano Hiroyuki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
GIST; imatinib; recurrence;

机译：GIST;伊马替尼;复发;

相似文献

外文文献
中文文献
专利

1. A Multicenter Long-Term Study of Imatinib Treatment for Japanese Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors [J] . Ogata Kyoichi, Mochiki Erito, Ojima Hitoshi, Journal of Surgical Oncology . 2014 ,第8期

机译：伊马替尼治疗日本不可切除或复发性胃肠道间质瘤患者的多中心长期研究
2. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels [J] . Casali Paolo G., Zalcberg John, Le Cesne Axel, Journal of Clinical Oncology . 2017 ,第15期

机译：患有不可切除或转移性胃肠基质肿瘤的患者的十年进展和整体生存：对欧洲癌症，意大利肉瘤组和澳大利亚胃肠试验组Intergrous阶段III阶段的癌症阶段III阶段III族随机试验的长期分析在两种剂量水平
3. A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. [J] . Ryu MH, Kang WK, Bang YJ, Oncology: International Journal of Cancer Research and Treatment . 2009 ,第5期

机译：甲磺酸伊马替尼在韩国患有转移性或不可切除的胃肠道间质瘤患者中的一项前瞻性，多中心，2期研究。
4. International classifications of gastrointestinal stromal tumor: a clue for adjuvant imatinib treatment [C] . Tzen Chin-Yuan International Gastric Cancer Congress . 2011

机译：胃肠道间质瘤的国际分类：佐剂伊马替尼治疗的线索
5. Molecular mechanisms of response in gastrointestinal stromal tumors treated with imatinib mesylate [D] . McAuliffe, John Christopher 2007

机译：甲磺酸伊马替尼治疗胃肠道间质瘤的分子机制
6. Long-term adjuvant imatinib treatment for a patient who underwent complete resection of a localized recurrent gastrointestinal stromal tumor after preoperative imatinib treatment [O] . Welda E.H. Tjhoi, Kai Li, Chun-hui Shou, -1

机译：术前伊马替尼治疗后彻底切除局部复发性胃肠道间质瘤的患者的长期辅助伊马替尼治疗
7. Surgery Prolongs the Survival of Patients with Metastatic, Recurrent, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Response to Imatinib Mesylate Treatment: A Systematic Review and Meta-analysis [O] . Weihao Li, Jianhong Peng, Xinyue Li, 2021

机译：手术延长了转移性，复发性或不可切除的局部晚期胃肠道间质谱对伊马替尼甲磺酸伊马替尼治疗的反应的患者的存活率：系统评价和荟萃分析

A Multicenter Long-Term Study of Imatinib Treatment for Japanese Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors

摘要

著录项

相似文献

相关主题

期刊订阅